PCSK9 INHIBITOR EVOLOCUMAB REDUCES CARDIOTOXICITYAND INFLAMMATION INDUCED BY DOXORUBICIN-HER2 BLOCKING AGENT SEQUENTIAL TREATMENT THROUGH MYD88/NF-KB/MTORC1 PATHWAYS
EUROPEAN HEART JOURNAL SUPPLEMENTS(2021)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined